Skip to main content
Fig. 5 | Experimental Hematology & Oncology

Fig. 5

From: Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma

Fig. 5

The effects of panel-TMB on OS in DLBCL patients of different ages, LDH levels, extranodal involvement, Ann Arbor stage, IPI, HBsAg, anti-HBc, and HBV-DNA in the GDPH dataset. LDH, lactate dehydrogenase; IPI, international prognostic index; HBsAg, hepatitis B surface antigen; anti-HBc, antibody to hepatitis B core antigen; HBV-DNA, hepatitis B virus DNA

Back to article page